Buscar
Mostrando ítems 11-20 de 223
Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude
(ELSEVIER SCI LTD, 2011)
Background: Homeopathy is based on the principle of similitude (similia similibus curentur) using medicines that cause effects similar to the symptoms of disease in order to stimulate the reaction of the organism. Such ...
Esofagitis eosinofílica: diagnóstico y manejo
(2021)
Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease, induced by food allergens, clinically characterized by symptoms of esophageal dysfunction. Pathologically there is a predominant eosinophilic inflammation. ...
Esofagitis eosinofílica: diagnóstico y manejo
(2020)
induced by food allergens, clinically characterized by symptoms of esophageal
dysfunction. Pathologically there is a predominant eosinophilic inflammation.
This disease is relatively new, and its definitions have evolved ...
Uso de inhibidores de bomba de protones como factor de riesgo para neumonía nosocomial
(Universidad Privada Antenor Orrego - UPAO, 2017)
INTRODUCCIÓN: La neumonía nosocomial es una enfermedad de elevada
morbimortalidad. Estudios recientes asocian el uso de inhibidores de bomba de protones a
su presentación.
OBJETIVO: Determinar si el uso de inhibidores ...
Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients
(Springer, 2020-10)
Background: Proton pump inhibitors (PPI)-related hypomagnesemia is a potentially life-threatening adverse event first described in 2006. PPIs are widely used in the general population. Information regarding prevalence and ...
Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard
(Ecv-editio Cantor Verlag Medizin Naturwissenschaften, 2004-01-01)
An analytical method based on liquid chromatography with positive ion electrospray ionization (ESI) coupled to tandem mass spectrometry detection was developed for the determination of pantoprazole (CAS 102625-70-7) in ...
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study
(Elsevier, 2015-03)
BACKGROUND & AIM Retrospective studies show an association between proton pump inhibitor (PPI) therapy and spontaneous bacterial peritonitis (SBP). We investigate the relationship between PPI and SBP in decompensated ...
The influence of omeprazole on the dissolution processes of ph-dependent magnetic tablets assessed by pharmacomagnetography
(2021-08-01)
Pharmacomagnetography involves the simultaneous assessment of solid dosage forms (SDFs) in the human gastrointestinal (GI) tract and the drug plasmatic concentration, using a biomagnetic technique and pharmacokinetics ...
Consumo prolongado de inhibidores de bomba de protones como factor de riesgo para síndrome de intestino irritable en pacientes adultos
(Universidad Privada Antenor OrregoPE, 2022)
Determinar que el consumo prolongado de inhibidores de
bomba de protones es un factor de riesgo para síndrome de intestino
irritable en pacientes adultos.
Material y Métodos: Se llevó a cabo un estudio de casos y ...
Reposicionamento de medicamentos em doenças infecciosas e avaliação da atividade biológica de inibidores da bomba de prótons e benzodiazepínicos
(Universidade Federal de Santa MariaBrasilAnálises Clínicas e ToxicológicasUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da Saúde, 2022-09-22)
A pathological condition with a high level of severity, caused by drug resistance, is one of the major public health
problems worldwide and has worrying consequences. This scenario becomes more complex when we mention ...